Mirum Adds To Rare Liver Disease Portfolio With Bluejay Acquisition

 
• By Joseph Haas
  
Acquisition deal
Acquiring Bluejay adds another rare liver disease asset to Mirum's portfolio (Shutterstock)

More from Deals

More from Business